LAUSR

Hepatobiliary cancers (HBC), including hepatocellular carcinoma (HCC) and cancers of the biliary tract, share high mortality and rising incidence rates. They may also share several risk factors related to unhealthy Western-type dietary and lifestyle patterns as well as increasing body weights and rates of obesity. Recent data also suggest a role for the gut microbiome in the development of HBC and other liver pathologies. The gut microbiome and the liver interact bidirectionally via the "gut-liver axis" which describes the interactive relationship between the gut, its microbiota and the liver. Here, we review the gut-liver interactions within the context of hepatobiliary carcinogenesis by outlining the experimental and observational evidence for the roles of gut microbiome dysbiosis, reduced gut barrier function and exposure to inflammatory compounds as well as metabolic dysfunction as contributors to HBC development. We also outline the latest findings regarding the impact of dietary and lifestyle factors on liver pathologies as mediated by the gut microbiome. Finally, we highlight some emerging gut microbiome editing techniques currently being investigated in the context of hepatobiliary diseases. Although much work remains to be done in determining the relationships between the gut microbiome and hepatobiliary diseases, emerging mechanistic insights are informing novel treatments such as potential microbiota manipulation strategies and guiding public health advice on dietary/lifestyle patterns for the prevention of these lethal cancers.